Richard A. Jorgensen (born 1951) is an American molecular geneticist and an early pioneer in the study of post transcriptional gene silencing.
From 1965 through 1969 he attended Loyola Academy in Wilmette, Illinois, a college preparatory school. Jorgensen holds a B.S. in biomedical engineering and a M.S. in chemistry from Northwestern University, which he attended from 1969 through 1973. In 1978, he received a Ph.D. in biochemistry from the University of Wisconsin–Madison. He did postdoctoral research at the Carnegie Institution's plant biology department at Stanford University with William F Thompson, and then at the University of California at Davis in the department of genetics with Robert W. Allard. From 1983 to 1990, he was employed at Advanced Genetic Sciences, Inc., which became DNA Plant Technology Corp., where he was director of floriculture genetic engineering and did the initial work on cosuppression. From 1990 to 1997, he was a research geneticist at UC Davis, and from 1997 to 2010 he was associate professor and then professor at the University of Arizona where he held the Bud Antle Chair for Excellence in Agricultural and Life Sciences.
His and Carolyn Napoli's observations of pigment gene "cosuppression" in Petunia flowers are examples of post transcriptional gene silencing that predated the discovery of RNA interference (RNAi) and contributed to the current understanding of the commonality of RNA-mediated gene silencing in eukaryotes. Their initial observations were made while working at the U.S. biotech company DNA Plant Technology and form part of the basis of a number of U.S. patents on gene regulation and crop manipulation. The significance of the discovery of cosuppression was described by NOVA scienceNOW in 2005. [1] Jorgensen's primary focus on the problem of cosuppression in petunia has been on the epigenetic aspects of the phenomenon and the relationship between cosuppression (RNAi) and epigenetics. Together with William Lucas at UC Davis and others he proposed the existence of an RNA Information Superhighway in plants by which information is transmitted throughout the plant via RNA molecules which influence gene expression and epigenetic state [2] Jorgensen was awarded the 2007 Martin Gibbs Medal by the American Society of Plant Biologists "for his pioneering work leading to the discovery of RNA interference (RNAi)." [3] He was elected an Inaugural Fellow of the American Society of Plant Biologists in 2007 [4] and a Fellow of the American Association for the Advancement of Sciences.
From 2003 through 2007 Jorgensen served as editor-in-chief of The Plant Cell , a research journal in plant biology. From 2007 to 2009 he was director of the iPlant Collaborative, a 5-year, $50 million project to develop cyberinfrastructure for the plant sciences. According to the US National Science Foundation (NSF) awarding agency, this was "the first national cyberinfrastructure center to tackle global "grand challenge" plant biology questions that have great implications on larger questions regarding the environment, agriculture, energy and the very organisms that sustain our existence on earth". [5] Researchers relied heavily on computational thinking, allowing them to focus on creative thinking a computer could not do.
Jorgensen became professor investigador at LANGEBIO (Laboratorio Nacional de Genomica para la Biodiversidad), a new research institute in the Mexican federal CINVESTAV research system located in Irapuato, Guanajuato, Mexico. He retained a title as professor emeritus in the School of Plant Sciences at the University of Arizona. His research interests are in computational biology.
Gene silencing is the regulation of gene expression in a cell to prevent the expression of a certain gene. Gene silencing can occur during either transcription or translation and is often used in research. In particular, methods used to silence genes are being increasingly used to produce therapeutics to combat cancer and other diseases, such as infectious diseases and neurodegenerative disorders.
Cold Spring Harbor Laboratory (CSHL) is a private, non-profit institution with research programs focusing on cancer, neuroscience, plant biology, genomics, and quantitative biology.
Phillip Allen Sharp is an American geneticist and molecular biologist who co-discovered RNA splicing. He shared the 1993 Nobel Prize in Physiology or Medicine with Richard J. Roberts for "the discovery that genes in eukaryotes are not contiguous strings but contain introns, and that the splicing of messenger RNA to delete those introns can occur in different ways, yielding different proteins from the same DNA sequence". He has been selected to receive the 2015 Othmer Gold Medal.
In epigenetics, a paramutation is an interaction between two alleles at a single locus, whereby one allele induces a heritable change in the other allele. The change may be in the pattern of DNA methylation or histone modifications. The allele inducing the change is said to be paramutagenic, while the allele that has been epigenetically altered is termed paramutable. A paramutable allele may have altered levels of gene expression, which may continue in offspring which inherit that allele, even though the paramutagenic allele may no longer be present. Through proper breeding, paramutation can result in siblings that have the same genetic sequence, but with drastically different phenotypes.
Craig Cameron Mello is an American biologist and professor of molecular medicine at the University of Massachusetts Medical School in Worcester, Massachusetts. He was awarded the 2006 Nobel Prize for Physiology or Medicine, along with Andrew Z. Fire, for the discovery of RNA interference. This research was conducted at the University of Massachusetts Medical School and published in 1998. Mello has been a Howard Hughes Medical Institute investigator since 2000.
Andrew Zachary Fire is an American biologist and professor of pathology and of genetics at the Stanford University School of Medicine. He was awarded the 2006 Nobel Prize in Physiology or Medicine, along with Craig C. Mello, for the discovery of RNA interference (RNAi). This research was conducted at the Carnegie Institution of Washington and published in 1998.
RNA silencing or RNA interference refers to a family of gene silencing effects by which gene expression is negatively regulated by non-coding RNAs such as microRNAs. RNA silencing may also be defined as sequence-specific regulation of gene expression triggered by double-stranded RNA (dsRNA). RNA silencing mechanisms are conserved among most eukaryotes. The most common and well-studied example is RNA interference (RNAi), in which endogenously expressed microRNA (miRNA) or exogenously derived small interfering RNA (siRNA) induces the degradation of complementary messenger RNA. Other classes of small RNA have been identified, including piwi-interacting RNA (piRNA) and its subspecies repeat associated small interfering RNA (rasiRNA).
Sir David Charles Baulcombe is a British plant scientist and geneticist. As of 2017 he is a Royal Society Research Professor. From 2007 to 2020 he was Regius Professor of Botany in the Department of Plant Sciences at the University of Cambridge.
RNA interference (RNAi) is a biological process in which RNA molecules are involved in sequence-specific suppression of gene expression by double-stranded RNA, through translational or transcriptional repression. Historically, RNAi was known by other names, including co-suppression, post-transcriptional gene silencing (PTGS), and quelling. The detailed study of each of these seemingly different processes elucidated that the identity of these phenomena were all actually RNAi. Andrew Fire and Craig C. Mello shared the 2006 Nobel Prize in Physiology or Medicine for their work on RNAi in the nematode worm Caenorhabditis elegans, which they published in 1998. Since the discovery of RNAi and its regulatory potentials, it has become evident that RNAi has immense potential in suppression of desired genes. RNAi is now known as precise, efficient, stable and better than antisense therapy for gene suppression. Antisense RNA produced intracellularly by an expression vector may be developed and find utility as novel therapeutic agents.
Ming-Ming Zhou is an American scientist whose specification is structural and chemical biology, NMR spectroscopy, and drug design. He is the Dr. Harold and Golden Lamport Professor and Chairman of the Department of Pharmacological Sciences. He is also the co-director of the Drug Discovery Institute at the Icahn School of Medicine at Mount Sinai and Mount Sinai Health System in New York City, as well as Professor of Sciences. Zhou is an elected fellow of the American Association for the Advancement of Science.
Transposable elements are short strands of repetitive DNA that can self-replicate and translocate within the eukaryotic genome, and are generally perceived as parasitic in nature. Their transcription can lead to the production of dsRNAs, which resemble retroviruses transcripts. While most host cellular RNA has a singular, unpaired sense strand, dsRNA possesses sense and anti-sense transcripts paired together, and this difference in structure allows an host organism to detect dsRNA production, and thereby the presence of transposons. Plants lack distinct divisions between somatic cells and reproductive cells, and also have, generally, larger genomes than animals, making them an intriguing case-study kingdom to be used in attempting to better understand the epigenetics function of transposable elements.
Shiv I.S. Grewal is an American scientist who is a distinguished investigator and laboratory chief at Center for Cancer Research, National Cancer Institute, National Institutes of Health, who studies the epigenetic control of higher-order chromatin assembly. His scientific career began at the University of Cambridge, where he held the prestigious Cambridge-Nehru scholarship and received Ph.D. in 1992. Then he joined National Cancer Institute as a postdoctoral fellow and found that the silenced states of gene expression can be propagated as epigenetic states. He continued to pursue his interests in the areas of epigenetic control of gene expression and development, joining Cold Spring Harbor Laboratory as an assistant professor in 1998, where he was promoted to associate professor in 2002. In 2003, he assumed a position of Senior Investigator at the Laboratory of Molecular Cell Biology, National Cancer Institute, where he was appointed distinguished investigator and laboratory chief in 2011.
Robert Anthony Martienssen is a British plant biologist, Howard Hughes Medical Institute–Gordon and Betty Moore Foundation investigator, and professor at Cold Spring Harbor Laboratory, US.
Robin Campbell Allshire is Professor of Chromosome Biology at University of Edinburgh and a Wellcome Trust Principal Research Fellow. His research group at the Wellcome Trust Centre for Cell Biology focuses on the epigenetic mechanisms governing the assembly of specialised domains of chromatin and their transmission through cell division.
Thomas Jenuwein is a German scientist working in the fields of epigenetics, chromatin biology, gene regulation and genome function.
Phillip D. Zamore is an American molecular biologist and developed the first in vitro system for studying the mechanism of RNA interference (RNAi). He is the Gretchen Stone Cook Professor of Biomedical Sciences and Professor of Biochemistry and Molecular Pharmacology at University of Massachusetts Chan Medical School, located in Worcester, Massachusetts. Zamore is the chair of the RNA Therapeutics Institute (RTI) at UMass Chan Medical School, established in 2009, and has been a Howard Hughes Medical Institute Investigator since 2008.
Richard William Carthew is a developmental biologist and quantitative biologist at Northwestern University. He is a professor of molecular biosciences and is the director of the NSF-Simons Center for Quantitative Biology.
Jian-Kang Zhu is a plant scientist, researcher and academic. He is a Senior Principal Investigator in the Shanghai Center for Plant Stress Biology, Chinese Academy of Sciences (CAS). He is also the Academic Director of CAS Center of Excellence in Plant Sciences.
RNA-directed DNA methylation (RdDM) is a biological process in which non-coding RNA molecules direct the addition of DNA methylation to specific DNA sequences. The RdDM pathway is unique to plants, although other mechanisms of RNA-directed chromatin modification have also been described in fungi and animals. To date, the RdDM pathway is best characterized within angiosperms, and particularly within the model plant Arabidopsis thaliana. However, conserved RdDM pathway components and associated small RNAs (sRNAs) have also been found in other groups of plants, such as gymnosperms and ferns. The RdDM pathway closely resembles other sRNA pathways, particularly the highly conserved RNAi pathway found in fungi, plants, and animals. Both the RdDM and RNAi pathways produce sRNAs and involve conserved Argonaute, Dicer and RNA-dependent RNA polymerase proteins.
James C. Carrington is a plant biologist and the current president of the Donald Danforth Plant Science Center. In 2005 he was elected a fellow of the American Association for the Advancement of Science and in 2008 he was elected to the National Academy of Sciences.